Keep up to date with us.
Find our latest news and company updates. For all media inquiries, contact us at email@example.com.
Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This
Velacur™️ ACE Outperforms FibroScan®️ CAP for Liver Fat Quantification We are excited to announce that clinical data from Sonic Incytes’
Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and
Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund.
Sonic Incytes Medical Corp. is pleased to announce clinical data from a prospective multi-center study comparing the effectiveness of Velacur™️
Sonic Incytes Medical Corp. is pleased to announce the inclusion of Velacur™️ — the first handheld 3D liver health assessment tool—in
The poster entitled “Accuracy of Velacur™️ AI Powered Liver Guide in Identification of Liver” presented at the Digestive Disease Week
Metabolic syndrome is a cluster of conditions that increase the risk of many chronic illnesses such as heart disease, stroke,
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Novel Tools for Managing Metabolic Syndrome. Metabolic
Following the closing of its US$7.3M Series A raise in December 2021, the Sonic Incytes Medical Corp. Board of Directors
Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its
Join us virtually on December 1 at 10AMPT/12PM CT/1PM ET at the 5th Annual NASH Summit 2021 to learn about
Sonic Incytes Medical Corp. has been selected as one of three finalists at the ADA’s 2021 Silicon Valley Leaders Forum
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Owning NAFLD Via Reimbursement Optimization. Join former
There is a certain thrill when you find parts and use them to build something new. For Sonic Incytes’ Lead
You’re invited! Join Sonic Incytes at ACG 2021. VelacurTM, the first handheld 3D liver health assessment solution, is coming to
If you practice in the field of liver disease, visit our booth at the 16th Annual National Liver Conference to
VelacurTM, the first handheld 3D liver health assessment solution, is coming to the 2021 Annual TSGE Conference, September 24 to
Be in-the-know on all our latest news!
Subscribe to our e-newsletter.